IMCR (STOCKS)
Immunocore Holdings plc American Depositary Shares
$28.630000
-0.330000 (-1.14%)
Prev close: $28.960000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Bahija Jallal
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,452.78M
- Employees
- 493
- P/E (TTM)
- -51.03
- P/B (TTM)
- 3.72
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
11
Buy
5
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.25 | $-0.26 | +0.5144 | +194.55% |
|
Dec 2025 (Q4)
|
$-0.60 | $-0.25 | -0.3519 | -141.84% |
|
Sep 2025 (Q3)
|
$0.00 | $-0.27 | +0.2664 | +100.00% |
|
Jun 2025 (Q2)
|
$-0.20 | $-0.20 | +0.0006 | +0.30% |
Financial Statements
| Revenues | $412.81M |
| Benefits Costs and Expenses | $424.72M |
| Cost Of Revenue | $4.69M |
| Costs And Expenses | $424.72M |
| Gross Profit | $408.12M |
| Operating Expenses | $442.58M |
| Selling, General, and Administrative Expenses | $163.07M |
| Research and Development | $279.51M |
| Operating Income/Loss | -$34.46M |
| Income/Loss From Continuing Operations After Tax | -$27.57M |
| Income/Loss From Continuing Operations Before Tax | -$11.91M |
| Income Tax Expense/Benefit | $15.65M |
| Net Income/Loss | -$27.57M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$27.57M |
| Net Income/Loss Available To Common Stockholders, Basic | -$27.57M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.54 |
| Diluted Earnings Per Share | -$0.55 |
| Basic Average Shares | 151,535,654 |
| Diluted Average Shares | 153,715,678 |
| Assets | $1.07B |
| Current Assets | $1.00B |
| Inventory | $8.25M |
| Other Current Assets | $995.55M |
| Noncurrent Assets | $68.29M |
| Fixed Assets | $12.13M |
| Other Non-current Assets | $56.16M |
| Liabilities | $678.42M |
| Current Liabilities | $240.11M |
| Accounts Payable | $30.16M |
| Wages | $5.23M |
| Other Current Liabilities | $204.73M |
| Noncurrent Liabilities | $438.31M |
| Equity | $393.67M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $393.67M |
| Liabilities And Equity | $1.07B |
| Net Cash Flow From Operating Activities | -$24.92M |
| Net Cash Flow From Operating Activities, Continuing | -$24.92M |
| Net Cash Flow From Investing Activities | -$21.82M |
| Net Cash Flow From Investing Activities, Continuing | -$21.82M |
| Net Cash Flow From Financing Activities | $10.48M |
| Net Cash Flow From Financing Activities, Continuing | $10.48M |
| Exchange Gains/Losses | $12.10M |
| Net Cash Flow | -$24.17M |
| Net Cash Flow, Continuing | -$36.27M |
| Comprehensive Income/Loss | -$29.85M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$29.85M |
| Other Comprehensive Income/Loss | $3.17M |